Correlation Between Xbrane Biopharma and Kollect On

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Xbrane Biopharma and Kollect On at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xbrane Biopharma and Kollect On into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xbrane Biopharma AB and Kollect on Demand, you can compare the effects of market volatilities on Xbrane Biopharma and Kollect On and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xbrane Biopharma with a short position of Kollect On. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xbrane Biopharma and Kollect On.

Diversification Opportunities for Xbrane Biopharma and Kollect On

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Xbrane and Kollect is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Xbrane Biopharma AB and Kollect on Demand in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kollect on Demand and Xbrane Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xbrane Biopharma AB are associated (or correlated) with Kollect On. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kollect on Demand has no effect on the direction of Xbrane Biopharma i.e., Xbrane Biopharma and Kollect On go up and down completely randomly.

Pair Corralation between Xbrane Biopharma and Kollect On

Assuming the 90 days trading horizon Xbrane Biopharma AB is expected to under-perform the Kollect On. In addition to that, Xbrane Biopharma is 1.61 times more volatile than Kollect on Demand. It trades about -0.03 of its total potential returns per unit of risk. Kollect on Demand is currently generating about 0.04 per unit of volatility. If you would invest  164.00  in Kollect on Demand on October 12, 2024 and sell it today you would earn a total of  106.00  from holding Kollect on Demand or generate 64.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Xbrane Biopharma AB  vs.  Kollect on Demand

 Performance 
       Timeline  
Xbrane Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Xbrane Biopharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Xbrane Biopharma is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Kollect on Demand 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Kollect on Demand are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Kollect On may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Xbrane Biopharma and Kollect On Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Xbrane Biopharma and Kollect On

The main advantage of trading using opposite Xbrane Biopharma and Kollect On positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xbrane Biopharma position performs unexpectedly, Kollect On can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kollect On will offset losses from the drop in Kollect On's long position.
The idea behind Xbrane Biopharma AB and Kollect on Demand pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios